AGP Executive Report
Last update: 8 hours agoPharma Push: Kazakhstan has cleared the way for a full-cycle biopharmaceutical complex in the Almaty region, with Prime Minister Olzhas Bektenov signing the resolution with Steppe Pharmaceuticals—aiming for commissioning in 2031, full capacity by 2032, and full-cycle operations by 2034; the project is backed by 32.5 billion tenge in private investment and is set to produce 20 medicine types, including oncology and rare-disease treatments, plus immunobiological products, R&D labs, GMP-standard manufacturing, and training for specialists. Healthcare Investment: The same week also brought renewed cooperation momentum as Kazakhstan and Pfizer advanced a healthcare investment project focused on modernizing infrastructure and improving access to innovative medicines. Emergency Readiness: Kazakhstan is also building a new resort complex for rescuers and preparing for international earthquake response drills, with plans to test coordination and readiness across agencies. Public Health Watch: Measles remains a concern in Zhetysu, where 85% of cases were among the unvaccinated, prompting ongoing case monitoring and investigations.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result.
Perspectify News
![Kazakhstan hosts event on 100th anniversary of First Baku Turkological Congress [PHOTOS]](https://www.azernews.az/media/2026/05/25/whatsapp_image_2026-05-25_at_111254.jpg)
